10x Genomics, Inc. (TXG) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 1010 transactions totaling $284.6M, demonstrating a bearish sentiment with -$284.6M in net insider flow. The most recent transaction on Feb 23, 2026 involved a sale of 7,826 shares valued at $145.4K.
No significant insider buying has been recorded for TXG in the recent period.
No significant insider selling has been recorded for TXG in the recent period.
Based on recent SEC filings, insider sentiment for TXG is bearish with an Insider Alignment Score of 0/100 and a net flow of -$284.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at 10x Genomics, Inc. (TXG) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading TXG stock, having executed 1010 transactions in the past 90 days. The most active insider is Benjamin J. Hindson (Executive), who has made 185 transactions totaling $120.7M.
Get notified when executives and directors at TXG file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | J. Hindson Benjamin | Executive | Sale | 7,826 | $18.58 | $145.4K | |
| Feb 23, 2026 | Taich Adam | Chief Financial Officer | Sale | 8,968 | $18.58 | $166.6K | C-Suite |
| Feb 23, 2026 | Saxonov Serge | Executive | Sale | 9,632 | $18.58 | $178.9K | |
| Nov 24, 2025 | Saxonov Serge | Executive | Sale | 13,261 | $19.00 | $252.0K | |
| Nov 24, 2025 | J. Hindson Benjamin | Executive | Sale | 8,283 | $19.00 | $157.4K | |
| Nov 24, 2025 | Taich Adam | Executive | Sale | 11,888 | $19.00 | $225.9K | |
| Sep 12, 2025 | Saxonov Serge | Executive | Gift | 900 | $N/A | $0 | |
| Aug 22, 2025 | J. Hindson Benjamin | Executive | Sale | 7,486 | $13.79 | $103.2K | |
| Aug 22, 2025 | Taich Adam | Executive | Sale | 22,315 | $13.79 | $307.7K | |
| Aug 22, 2025 | Saxonov Serge | Executive | Sale | 9,348 | $13.79 | $128.9K | |
| Aug 30, 2024 | A. Teichmann Sarah | Executive | Award | 19,002 | $N/A | $0 | |
| Aug 22, 2024 | J. Mcanear Justin | Executive | Sale | 2,961 | $22.53 | $66.7K | |
| Aug 22, 2024 | J. Hindson Benjamin | Executive | Sale | 4,351 | $22.53 | $98.0K | |
| Aug 22, 2024 | Saxonov Serge | Executive | Sale | 6,749 | $22.53 | $152.1K | |
| Jul 31, 2024 | Mateo Alan | Executive | Award | 21,691 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 800 | $284.6M | 96.6% |
Exercise(M) | 131 | $9.9M | 3.4% |
Purchase(P) | 2 | $12.8K | 0.0% |
Gift(G) | 21 | $0 | 0.0% |
Award(A) | 42 | $0 | 0.0% |
Conversion(C) | 4 | $0 | 0.0% |
Other(J) | 10 | $0 | 0.0% |
Insider selling pressure at 10x Genomics, Inc. has increased, with 16 insiders executing 1010 transactions across all time. Total sales of $284.6M significantly outpace purchases of $12.8K, resulting in a net outflow of $284.6M. This selling activity appears largely discretionary, which may warrant closer attention from investors.